Literature DB >> 20640436

Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice.

Weiyun Shi1, Chunping Ming, Juncai Liu, Ting Wang, Hua Gao.   

Abstract

PURPOSE: To analyze the features of corneal neovascularization and lymphangiogenesis induced by different etiological factors.
METHODS: A total of 150 mice were randomly divided into five groups to establish models of corneal neovascularization and lymphangiogenesis by alkali burn, suturing, fungal infection, bovine serum albumin (BSA) injection, and tumor cell implantation, respectively. Morphology and length and quantity of corneal neovascularization were monitored daily by slit-lamp microscopy. Histopathological changes were evaluated on days 1, 3, 7, and 14. New lymphatic vessels stained by LYVE-1 and neovascularized vessels stained by anti-CD31 monoclonal antibody were observed on days 3, 7, 14, and 21. Expression of VEGF-A, VEGF-C and VEGFR-3 in corneal tissue was detected by semi-quantitative RT-PCR on days 7 and 14.
RESULTS: The shape of corneal neovascularization was dendritic in the alkali burn model, elongated in the suturing model, mushroom-like in the fungal infection model, broadband-like in the BSA injection model, and umbrella-like in the tumor cell implantation model. Inflammatory cells appeared from day 1 and accompanied neovascularization from day 3 to day 14. When the inflammatory cells retreated, neovascularization was seen in the corneal stroma. The onset of lymphangiogenesis was later than neovascularization in all groups. The pathologic lymphatic vessels grew slowly in the fungal infection and tumor cell implantation models and at a high density in the BSA injection model. When the area of neovascularization and lymphatic vessels increased, the expression of VEGFs maintained to be effective.
CONCLUSIONS: Corneal neovascularization and lymphangiogenesis induced by different etiological factors show different growth patterns. Inflammatory reaction plays a part in the induction of corneal neovascularization. A certain level of VEGFs in corneal tissue may sustain the presentation of corneal neovascularization and lymphangiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640436     DOI: 10.1007/s00417-010-1442-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  20 in total

Review 1.  VEGF receptor signalling - in control of vascular function.

Authors:  Anna-Karin Olsson; Anna Dimberg; Johan Kreuger; Lena Claesson-Welsh
Journal:  Nat Rev Mol Cell Biol       Date:  2006-05       Impact factor: 94.444

2.  Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.

Authors:  Kenneth LaMontagne; Amanda Littlewood-Evans; Christian Schnell; Terence O'Reilly; Lorenza Wyder; Teresa Sanchez; Beatrice Probst; Jeannene Butler; Alexander Wood; Gene Liau; Eric Billy; Andreas Theuer; Timothy Hla; Jeanette Wood
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

3.  Lymphangiogenesis occurring in transplanted corneas.

Authors:  Shiqi Ling; Xiao Qing; Yanhua Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.

Authors:  J L Edelman; M R Castro; Y Wen
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-05       Impact factor: 4.799

5.  Absence of blood and lymphatic vessels in the developing human cornea.

Authors:  Claus Cursiefen; Carmen Rummelt; Anselm Jünemann; Christian Vorwerk; Winfried Neuhuber; Friedrich E Kruse; Falk Schroedl
Journal:  Cornea       Date:  2006-07       Impact factor: 2.651

Review 6.  Lymphangiogenic growth factors, receptors and therapies.

Authors:  Marja Lohela; Anne Saaristo; Tanja Veikkola; Kari Alitalo
Journal:  Thromb Haemost       Date:  2003-08       Impact factor: 5.249

7.  Dose-dependent response of FGF-2 for lymphangiogenesis.

Authors:  Lynn K Chang; Guillermo Garcia-Cardeña; Filip Farnebo; Michael Fannon; Emy J Chen; Catherine Butterfield; Marsha A Moses; Richard C Mulligan; Judah Folkman; Arja Kaipainen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

8.  The expression of vascular endothelial growth factor C in transplanted corneas.

Authors:  Shiqi Ling; Chaoxiu Qi; Wei Li; Jiangang Xu; Wenghui Kuang
Journal:  Curr Eye Res       Date:  2009-07       Impact factor: 2.424

9.  Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells.

Authors:  T A Brock; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

Review 10.  Lymphangiogenesis and cancer metastasis.

Authors:  Steven A Stacker; Marc G Achen; Lotta Jussila; Megan E Baldwin; Kari Alitalo
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  2 in total

1.  Tissue and cellular characterisation of nucleolin in a murine model of corneal angiogenesis.

Authors:  Joaquín Quiroz-Mercado; Norma Ramírez-Velázquez; Graciela Partido; Edgar Zenteno; Raúl Chávez; Concepción Agundis-Mata; Maria Carmen Jiménez-Martínez; Yonathan Garfias
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-16       Impact factor: 3.117

2.  Triamcinolone acetonide as an adjunct to bevacizumab for prevention of corneal neovascularization in a rat model.

Authors:  Hadi Z Mehrjardi; Reza Ghaffari; Mirgholamreza Mahbod; Hassan Hashemi
Journal:  J Ophthalmic Vis Res       Date:  2014-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.